DOI: 10.1016/j.ejphar.2006.07.024. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice

Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice

10.1016/j.ejphar.2006.07.024

Crossref journal-article

Elsevier BV

European Journal of Pharmacology (78)

Bibliography

Haller, V. L., Cichewicz, D. L., & Welch, S. P. (2006). Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. European Journal of Pharmacology, 546(1â3), 60â68.

Authors 3

Victoria L. Haller (first)
Diana L. Cichewicz (additional)
Sandra P. Welch (additional)

References 43 Referenced 31

10.1021/jm00038a020 / J. Med. Chem. / (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability by Abadji (1994)
10.1124/jpet.303.1.340 / J. Pharmacol. Exp. Ther. / Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta (9)-tetrahydrocannabinol administration by Anikwue (2002)
10.1016/S0014-2999(02)01369-9 / Eur. J. Pharmacol. / Arvanil-induced inhibiton of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors by Brooks (2002)
10.1038/28393 / Nature / Control of pain initiation by endogenous cannabinoids by Calignano (1998)
10.1016/S0022-3565(24)38212-6 / J. Pharmacol. Exp. Ther. / Enhancement of mu opioid antinociception by oral delta (9)-tetrahydrocannabinol: dose-response analysis and receptor identification by Cichewicz (1999)
10.1016/S0022-3565(24)29518-5 / J. Pharmacol. Exp. Ther. / Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta (9)-tetrahydrocannabinol and morphine by Cichewicz (2001)
{'key': '10.1016/j.ejphar.2006.07.024_bib7', 'first-page': '586', 'article-title': 'In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity', 'volume': '277', 'author': 'Compton', 'year': '1996', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity by Compton (1996)
10.1073/pnas.161191698 / Proc. Natl. Acad. Sci. U. S. A. / Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase by Cravatt (2001)
10.1016/S0014-5793(00)02082-2 / FEBS Lett. / Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity by De Petrocellis (2000)
10.1126/science.1470919 / Science / Isolation and structure of a brain constituent that binds to the cannabinoid receptor by Devane (1992)
10.1016/S0005-2760(98)00042-3 / Biochim. Biophys. Acta / ‘Endocannabinoids’, and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance by Di Marzo (1998)
10.1016/S0014-2999(00)00687-7 / Eur. J. Pharmacol. / Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide by Di Marzo (2000)
10.1046/j.1471-4159.2000.0752434.x / J. Neurochem. / Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain by Di Marzo (2000)
10.1016/S0090-6980(00)00054-X / Prostaglandins Other Lipid Mediat. / Cannabimimetic fatty acid derivatives in cancer and inflammation by Di Marzo (2000)
10.1007/BF01965625 / Agents Actions / The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia by Dubinsky (1987)
10.1124/jpet.104.078980 / J. Pharmacol. Exp. Ther. / Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide by Fegley (2005)
10.1021/ja01062a046 / J. Am. Chem. Soc. / Isolation, structure and partial synthesis of an active constituent of hashish by Gaoni (1964)
10.1097/00045391-200501000-00008 / Am. J. Ther. / Mechanism of action of paracetamol by Graham (2005)
10.1016/S0024-3205(03)00651-9 / Life Sci. / Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat by Helyes (2003)
10.1073/pnas.87.5.1932 / Proc. Natl. Acad. Sci. U. S. A. / Cannabinoid receptor localization in brain by Herkenham (1990)
10.1074/jbc.M501489200 / J. Biol. Chem. / Conversion of acetaminophen to the bioactive N-Acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system by Högestätt (2005)
10.1016/S0006-8993(00)01981-8 / Brain Res. / Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide by Houser (2000)
10.1016/S0304-3940(98)00621-1 / Neurosci. Lett. / The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder by Jaggar (1998)
10.1038/nm803 / Nat. Med. / Modulation of anxiety through blockade of anandamide hydrolysis by Kathuria (2003)
10.2174/0929867306666220401153732 / Curr. Med. Chem. / The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? by Lambert (1999)
10.1016/0091-3057(91)90349-7 / Pharmacol. Biochem. Behav. / Behavioral, biochemical and molecular modeling evaluations of cannabinoid analogs by Martin (1991)
10.1038/346561a0 / Nature / Structure of a cannabinoid receptor and functional expression of the cloned cDNA by Matsuda (1990)
10.1016/0014-2999(96)00015-5 / Eur. J. Pharmacol. / N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation by Mazzari (1996)
10.1006/bbrc.1999.1105 / Biochem. Biophys. Res. Commun. / Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors by Melck (1999)
{'key': '10.1016/j.ejphar.2006.07.024_bib30', 'first-page': '217', 'article-title': 'Prevention of writhing and other effects of narcotics and narcotic antagonists in mice', 'volume': '160', 'author': 'Pearl', 'year': '1968', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Prevention of writhing and other effects of narcotics and narcotic antagonists in mice by Pearl (1968)
{'key': '10.1016/j.ejphar.2006.07.024_bib31', 'first-page': '608', 'article-title': 'The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord', 'volume': '279', 'author': 'Pugh', 'year': '1996', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord by Pugh (1996)
10.1006/bbrc.2001.5518 / Biochem. Biophys. Res. Commun. / R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism by Ramer (2001)
10.1016/S0197-0186(99)00020-0 / Neurochem. Int. / Cannabinoid receptor and WIN-55,212-2-stimulated [35S] GTPγS binding and cannabinoid receptor mRNA levels in several brain structures in adult male rats chronically exposed to R-methanandamide by Romero (1999)
10.1038/sj.bjp.0703850 / Br. J. Pharmacol. / Structure-activity relationship for the endogenous cannabinoid, anadamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens by Ross (2001)
{'key': '10.1016/j.ejphar.2006.07.024_bib36', 'first-page': '1381', 'article-title': 'Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice', 'volume': '268', 'author': 'Smith', 'year': '1994', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice by Smith (1994)
10.1016/S0091-3057(98)00012-4 / Pharmacol. Biochem. Behav. / The enhancement of morphine antinociception in mice by Δ9-tetrahydrocannabinol by Smith (1998)
10.1309/7AYY-VVH1-GQT5-J4R2 / Am. J. Clin. Pathol. / Vanilloid (capsaicin) receptors in health and disease by Szallasi (2002)
10.1016/S0166-2236(00)01630-1 / Trends Neurosci. / New perspectives on enigmatic vanilloid receptors by Szallasi (2000)
10.1021/jm030560j / J. Med. Chem. / Vanilloid receptor TRPV1 antagonist as the next generation of painkillers. Are we putting the cart before the horse? by Szallasi (2004)
{'year': '1987', 'series-title': 'Procedures 5 and 8 in Manual of Pharmacologic Calculations with Computer Programs', 'author': 'Tallarida', 'key': '10.1016/j.ejphar.2006.07.024_bib39'} / Procedures 5 and 8 in Manual of Pharmacologic Calculations with Computer Programs by Tallarida (1987)
10.1016/S0376-8716(97)01342-2 / Drug Alcohol Depend. / Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems by Welch (1997)
{'key': '10.1016/j.ejphar.2006.07.024_bib41', 'first-page': '1235', 'article-title': 'Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception', 'volume': '273', 'author': 'Welch', 'year': '1995', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception by Welch (1995)
10.1038/22761 / Nature / Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide by Zygmunt (1999)

Dates

Type	When
Created	19 years, 1 month ago (July 26, 2006, 9:13 a.m.)
Deposited	7 months, 3 weeks ago (Jan. 9, 2025, 9:50 p.m.)
Indexed	4 months, 3 weeks ago (April 8, 2025, 7:01 p.m.)
Issued	19 years ago (Sept. 1, 2006)
Published	19 years ago (Sept. 1, 2006)
Published Print	19 years ago (Sept. 1, 2006)

Funders 0

None

BibTeX

@article{Haller_2006, title={Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice}, volume={546}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/j.ejphar.2006.07.024}, DOI={10.1016/j.ejphar.2006.07.024}, number={1–3}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Haller, Victoria L. and Cichewicz, Diana L. and Welch, Sandra P.}, year={2006}, month=sep, pages={60–68} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        4,
        8
      ]
    ],
    "date-time": "2025-04-08T23:01:04Z",
    "timestamp": 1744153264156,
    "version": "3.32.0"
  },
  "reference-count": 43,
  "publisher": "Elsevier BV",
  "issue": "1-3",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2006,
            9,
            1
          ]
        ],
        "date-time": "2006-09-01T00:00:00Z",
        "timestamp": 1157068800000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2006,
        9
      ]
    ]
  },
  "DOI": "10.1016/j.ejphar.2006.07.024",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2006,
        7,
        26
      ]
    ],
    "date-time": "2006-07-26T13:13:33Z",
    "timestamp": 1153919613000
  },
  "page": "60-68",
  "source": "Crossref",
  "is-referenced-by-count": 31,
  "title": "Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice",
  "prefix": "10.1016",
  "volume": "546",
  "author": [
    {
      "given": "Victoria L.",
      "family": "Haller",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Diana L.",
      "family": "Cichewicz",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Sandra P.",
      "family": "Welch",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib1",
      "doi-asserted-by": "crossref",
      "first-page": "1889",
      "DOI": "10.1021/jm00038a020",
      "article-title": "(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability",
      "volume": "37",
      "author": "Abadji",
      "year": "1994",
      "journal-title": "J. Med. Chem."
    },
    {
      "issue": "1",
      "key": "10.1016/j.ejphar.2006.07.024_bib2",
      "doi-asserted-by": "crossref",
      "first-page": "340",
      "DOI": "10.1124/jpet.303.1.340",
      "article-title": "Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta (9)-tetrahydrocannabinol administration",
      "volume": "303",
      "author": "Anikwue",
      "year": "2002",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib3",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.1016/S0014-2999(02)01369-9",
      "article-title": "Arvanil-induced inhibiton of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors",
      "volume": "439",
      "author": "Brooks",
      "year": "2002",
      "journal-title": "Eur. J. Pharmacol."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib4",
      "doi-asserted-by": "crossref",
      "first-page": "277",
      "DOI": "10.1038/28393",
      "article-title": "Control of pain initiation by endogenous cannabinoids",
      "volume": "394",
      "author": "Calignano",
      "year": "1998",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib5",
      "doi-asserted-by": "crossref",
      "first-page": "859",
      "DOI": "10.1016/S0022-3565(24)38212-6",
      "article-title": "Enhancement of mu opioid antinociception by oral delta (9)-tetrahydrocannabinol: dose-response analysis and receptor identification",
      "volume": "289",
      "author": "Cichewicz",
      "year": "1999",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib6",
      "doi-asserted-by": "crossref",
      "first-page": "121",
      "DOI": "10.1016/S0022-3565(24)29518-5",
      "article-title": "Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta (9)-tetrahydrocannabinol and morphine",
      "volume": "297",
      "author": "Cichewicz",
      "year": "2001",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib7",
      "first-page": "586",
      "article-title": "In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity",
      "volume": "277",
      "author": "Compton",
      "year": "1996",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "issue": "16",
      "key": "10.1016/j.ejphar.2006.07.024_bib8",
      "doi-asserted-by": "crossref",
      "first-page": "9371",
      "DOI": "10.1073/pnas.161191698",
      "article-title": "Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase",
      "volume": "98",
      "author": "Cravatt",
      "year": "2001",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib9",
      "doi-asserted-by": "crossref",
      "first-page": "52",
      "DOI": "10.1016/S0014-5793(00)02082-2",
      "article-title": "Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity",
      "volume": "483",
      "author": "De Petrocellis",
      "year": "2000",
      "journal-title": "FEBS Lett."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib10",
      "doi-asserted-by": "crossref",
      "first-page": "1946",
      "DOI": "10.1126/science.1470919",
      "article-title": "Isolation and structure of a brain constituent that binds to the cannabinoid receptor",
      "volume": "258",
      "author": "Devane",
      "year": "1992",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib11",
      "doi-asserted-by": "crossref",
      "first-page": "153",
      "DOI": "10.1016/S0005-2760(98)00042-3",
      "article-title": "\u2018Endocannabinoids\u2019, and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance",
      "volume": "1392",
      "author": "Di Marzo",
      "year": "1998",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib12",
      "doi-asserted-by": "crossref",
      "first-page": "363",
      "DOI": "10.1016/S0014-2999(00)00687-7",
      "article-title": "Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide",
      "volume": "406",
      "author": "Di Marzo",
      "year": "2000",
      "journal-title": "Eur. J. Pharmacol."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib13",
      "doi-asserted-by": "crossref",
      "first-page": "2434",
      "DOI": "10.1046/j.1471-4159.2000.0752434.x",
      "article-title": "Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain",
      "volume": "75",
      "author": "Di Marzo",
      "year": "2000",
      "journal-title": "J. Neurochem."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib14",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "DOI": "10.1016/S0090-6980(00)00054-X",
      "article-title": "Cannabimimetic fatty acid derivatives in cancer and inflammation",
      "volume": "61",
      "author": "Di Marzo",
      "year": "2000",
      "journal-title": "Prostaglandins Other Lipid Mediat."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib15",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "DOI": "10.1007/BF01965625",
      "article-title": "The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia",
      "volume": "20",
      "author": "Dubinsky",
      "year": "1987",
      "journal-title": "Agents Actions"
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib16",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "DOI": "10.1124/jpet.104.078980",
      "article-title": "Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2032-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide",
      "volume": "313",
      "author": "Fegley",
      "year": "2005",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib17",
      "doi-asserted-by": "crossref",
      "first-page": "1646",
      "DOI": "10.1021/ja01062a046",
      "article-title": "Isolation, structure and partial synthesis of an active constituent of hashish",
      "volume": "86",
      "author": "Gaoni",
      "year": "1964",
      "journal-title": "J. Am. Chem. Soc."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib18",
      "doi-asserted-by": "crossref",
      "first-page": "46",
      "DOI": "10.1097/00045391-200501000-00008",
      "article-title": "Mechanism of action of paracetamol",
      "volume": "12",
      "author": "Graham",
      "year": "2005",
      "journal-title": "Am. J. Ther."
    },
    {
      "issue": "18",
      "key": "10.1016/j.ejphar.2006.07.024_bib19",
      "doi-asserted-by": "crossref",
      "first-page": "2345",
      "DOI": "10.1016/S0024-3205(03)00651-9",
      "article-title": "Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat",
      "volume": "73",
      "author": "Helyes",
      "year": "2003",
      "journal-title": "Life Sci."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib20",
      "doi-asserted-by": "crossref",
      "first-page": "1932",
      "DOI": "10.1073/pnas.87.5.1932",
      "article-title": "Cannabinoid receptor localization in brain",
      "volume": "87",
      "author": "Herkenham",
      "year": "1990",
      "journal-title": "Proc. Natl. Acad. Sci. U. S. A."
    },
    {
      "issue": "36",
      "key": "10.1016/j.ejphar.2006.07.024_bib21",
      "doi-asserted-by": "crossref",
      "first-page": "31405",
      "DOI": "10.1074/jbc.M501489200",
      "article-title": "Conversion of acetaminophen to the bioactive N-Acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system",
      "volume": "280",
      "author": "H\u00f6gest\u00e4tt",
      "year": "2005",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib22",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "DOI": "10.1016/S0006-8993(00)01981-8",
      "article-title": "Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, \u03949-THC and anandamide",
      "volume": "857",
      "author": "Houser",
      "year": "2000",
      "journal-title": "Brain Res."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib23",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "DOI": "10.1016/S0304-3940(98)00621-1",
      "article-title": "The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder",
      "volume": "253",
      "author": "Jaggar",
      "year": "1998",
      "journal-title": "Neurosci. Lett."
    },
    {
      "issue": "9",
      "key": "10.1016/j.ejphar.2006.07.024_bib24",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "DOI": "10.1038/nm803",
      "article-title": "Modulation of anxiety through blockade of anandamide hydrolysis",
      "volume": "1",
      "author": "Kathuria",
      "year": "2003",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib25",
      "doi-asserted-by": "crossref",
      "first-page": "757",
      "DOI": "10.2174/0929867306666220401153732",
      "article-title": "The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic?",
      "volume": "6",
      "author": "Lambert",
      "year": "1999",
      "journal-title": "Curr. Med. Chem."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib26",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "DOI": "10.1016/0091-3057(91)90349-7",
      "article-title": "Behavioral, biochemical and molecular modeling evaluations of cannabinoid analogs",
      "volume": "40",
      "author": "Martin",
      "year": "1991",
      "journal-title": "Pharmacol. Biochem. Behav."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib27",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1038/346561a0",
      "article-title": "Structure of a cannabinoid receptor and functional expression of the cloned cDNA",
      "volume": "346",
      "author": "Matsuda",
      "year": "1990",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib28",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "DOI": "10.1016/0014-2999(96)00015-5",
      "article-title": "N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation",
      "volume": "300",
      "author": "Mazzari",
      "year": "1996",
      "journal-title": "Eur. J. Pharmacol."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib29",
      "doi-asserted-by": "crossref",
      "first-page": "275",
      "DOI": "10.1006/bbrc.1999.1105",
      "article-title": "Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors",
      "volume": "262",
      "author": "Melck",
      "year": "1999",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib30",
      "first-page": "217",
      "article-title": "Prevention of writhing and other effects of narcotics and narcotic antagonists in mice",
      "volume": "160",
      "author": "Pearl",
      "year": "1968",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib31",
      "first-page": "608",
      "article-title": "The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord",
      "volume": "279",
      "author": "Pugh",
      "year": "1996",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib32",
      "doi-asserted-by": "crossref",
      "first-page": "1144",
      "DOI": "10.1006/bbrc.2001.5518",
      "article-title": "R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism",
      "volume": "286",
      "author": "Ramer",
      "year": "2001",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib33",
      "doi-asserted-by": "crossref",
      "first-page": "473",
      "DOI": "10.1016/S0197-0186(99)00020-0",
      "article-title": "Cannabinoid receptor and WIN-55,212-2-stimulated [35S] GTP\u03b3S binding and cannabinoid receptor mRNA levels in several brain structures in adult male rats chronically exposed to R-methanandamide",
      "volume": "34",
      "author": "Romero",
      "year": "1999",
      "journal-title": "Neurochem. Int."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib34",
      "doi-asserted-by": "crossref",
      "first-page": "631",
      "DOI": "10.1038/sj.bjp.0703850",
      "article-title": "Structure-activity relationship for the endogenous cannabinoid, anadamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens",
      "volume": "132",
      "author": "Ross",
      "year": "2001",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib36",
      "first-page": "1381",
      "article-title": "Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice",
      "volume": "268",
      "author": "Smith",
      "year": "1994",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib37",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "DOI": "10.1016/S0091-3057(98)00012-4",
      "article-title": "The enhancement of morphine antinociception in mice by \u03949-tetrahydrocannabinol",
      "volume": "60",
      "author": "Smith",
      "year": "1998",
      "journal-title": "Pharmacol. Biochem. Behav."
    },
    {
      "issue": "1",
      "key": "10.1016/j.ejphar.2006.07.024_bib43",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "DOI": "10.1309/7AYY-VVH1-GQT5-J4R2",
      "article-title": "Vanilloid (capsaicin) receptors in health and disease",
      "volume": "118",
      "author": "Szallasi",
      "year": "2002",
      "journal-title": "Am. J. Clin. Pathol."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib38",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "DOI": "10.1016/S0166-2236(00)01630-1",
      "article-title": "New perspectives on enigmatic vanilloid receptors",
      "volume": "23",
      "author": "Szallasi",
      "year": "2000",
      "journal-title": "Trends Neurosci."
    },
    {
      "issue": "11",
      "key": "10.1016/j.ejphar.2006.07.024_bib44",
      "doi-asserted-by": "crossref",
      "first-page": "2717",
      "DOI": "10.1021/jm030560j",
      "article-title": "Vanilloid receptor TRPV1 antagonist as the next generation of painkillers. Are we putting the cart before the horse?",
      "volume": "47",
      "author": "Szallasi",
      "year": "2004",
      "journal-title": "J. Med. Chem."
    },
    {
      "year": "1987",
      "series-title": "Procedures 5 and 8 in Manual of Pharmacologic Calculations with Computer Programs",
      "author": "Tallarida",
      "key": "10.1016/j.ejphar.2006.07.024_bib39"
    },
    {
      "issue": "1\u20132",
      "key": "10.1016/j.ejphar.2006.07.024_bib40",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "DOI": "10.1016/S0376-8716(97)01342-2",
      "article-title": "Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems",
      "volume": "45",
      "author": "Welch",
      "year": "1997",
      "journal-title": "Drug Alcohol Depend."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib41",
      "first-page": "1235",
      "article-title": "Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception",
      "volume": "273",
      "author": "Welch",
      "year": "1995",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "10.1016/j.ejphar.2006.07.024_bib42",
      "doi-asserted-by": "crossref",
      "first-page": "452",
      "DOI": "10.1038/22761",
      "article-title": "Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide",
      "volume": "400",
      "author": "Zygmunt",
      "year": "1999",
      "journal-title": "Nature"
    }
  ],
  "container-title": "European Journal of Pharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0014299906007540?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0014299906007540?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2025,
        1,
        10
      ]
    ],
    "date-time": "2025-01-10T02:50:59Z",
    "timestamp": 1736477459000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0014299906007540"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2006,
        9
      ]
    ]
  },
  "references-count": 43,
  "journal-issue": {
    "issue": "1-3",
    "published-print": {
      "date-parts": [
        [
          2006,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "S0014299906007540"
  ],
  "URL": "http://dx.doi.org/10.1016/j.ejphar.2006.07.024",
  "relation": {},
  "ISSN": [
    "0014-2999"
  ],
  "subject": [],
  "container-title-short": "European Journal of Pharmacology",
  "published": {
    "date-parts": [
      [
        2006,
        9
      ]
    ]
  }
}